Price T Rowe Associates Inc Amicus Therapeutics, Inc. Transaction History

Price T Rowe Associates Inc

$869 Billion
Q3 2024

A detailed history of Price T Rowe Associates Inc transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 1,341,921 shares of FOLD stock, worth $13 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,341,921

Previous 1,390,047 3.46%

Holding current value

$13 Million

Previous $13.8 Million 3.93%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$9.55 - $12.09 $459,603 - $581,843	-48,126 Reduced 3.46%	1,341,921 $14.3 Million
Q2 2024 Aug 14, 2024	BUY	$9.04 - $11.75 $6,201 - $8,060	686 Added 0.05%	1,390,047 $13.8 Million
Q1 2024 May 15, 2024	BUY	$11.43 - $14.24 $137,194 - $170,922	12,003 Added 0.87%	1,389,361 $16.4 Million
Q4 2023 Feb 14, 2024	SELL	$9.97 - $14.52 $196,777 - $286,581	-19,737 Reduced 1.41%	1,377,358 $19.5 Million
Q3 2023 Nov 14, 2023	BUY	$11.78 - $13.86 $52,786 - $62,106	4,481 Added 0.32%	1,397,095 $17 Million
Q2 2023 Aug 14, 2023	SELL	$10.72 - $13.3 $818,879 - $1.02 Million	-76,388 Reduced 5.2%	1,392,614 $17.5 Million
Q1 2023 May 15, 2023	SELL	$10.91 - $13.54 $231,215 - $286,953	-21,193 Reduced 1.42%	1,469,002 $16.3 Million
Q4 2022 Feb 14, 2023	BUY	$9.89 - $12.7 $311,287 - $399,732	31,475 Added 2.16%	1,490,195 $18.2 Million
Q3 2022 Nov 14, 2022	SELL	$9.82 - $12.75 $71,440 - $92,756	-7,275 Reduced 0.5%	1,458,720 $15.2 Million
Q2 2022 Aug 15, 2022	BUY	$6.23 - $11.12 $30,302 - $54,087	4,864 Added 0.33%	1,465,995 $15.7 Million
Q1 2022 May 16, 2022	SELL	$7.89 - $12.48 $4.77 Million - $7.54 Million	-604,011 Reduced 29.25%	1,461,131 $13.8 Million
Q4 2021 Feb 14, 2022	SELL	$9.82 - $12.44 $6.99 Million - $8.86 Million	-712,106 Reduced 25.64%	2,065,142 $23.9 Million
Q3 2021 Nov 15, 2021	BUY	$8.74 - $11.84 $1.83 Million - $2.48 Million	209,572 Added 8.16%	2,777,248 $26.5 Million
Q2 2021 Aug 16, 2021	BUY	$8.71 - $10.72 $4.2 Million - $5.17 Million	482,004 Added 23.11%	2,567,676 $24.8 Million
Q1 2021 May 17, 2021	BUY	$9.2 - $23.86 $334,052 - $866,356	36,310 Added 1.77%	2,085,672 $20.6 Million
Q4 2020 Feb 16, 2021	BUY	$13.47 - $24.89 $27.6 Million - $51 Million	2,049,362 New	2,049,362 $47.3 Million

Others Institutions Holding FOLD

# of Institutions

313

Shares Held

314M

Call Options Held

516K

Put Options Held

833K

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.73B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Amicus Therapeutics, Inc. Transaction History